A Phase II Multi-center, Open Label, Randomized Study to Assess Safety and Efficacy of Two Different Schedules of Oral LDE225 in Adult Patients With Relapsed/Refractory or Untreated Elderly Patients With Acute Leukemia
Phase of Trial: Phase II
Latest Information Update: 07 Jul 2016
At a glance
- Drugs Sonidegib (Primary)
- Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Novartis; Novartis Pharmaceuticals
- 13 Oct 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 22 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 04 Apr 2014 Planned End Date changed from 1 Feb 2015 to 1 Jun 2015 as reported by ClinicalTrials. gov record.